直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 117182
著者
Hatakeyama, S Sakamoto Hospital
Okada, M Tokushima University
板東, 浩 Sakamoto Hospital|Tokushima University KAKEN研究者をさがす
Iwatsuki, N Sakamoto Hospital
Sakamoto, K Sakamoto Hospital
Ogawa, T Sakamoto Hospital
キーワード
Oral hypoglycemic agent (OHA)
Imeglimin
Twymeeg
Tetrahydrotriazine
Trials of IMeglimin for Efficacy and Safety (TIMES)
資料タイプ
学術雑誌論文
抄録
Background: A novel oral hypoglycemic agent (OHA) would be imeglimin (Twymeeg) as tetrahydrotriazine-containing drug.
Case presentation: The patient is 93-year-old female and developed appetite loss and slower vocal response in March, 2022.
Result: She was transferred to our hospital, and diagnosed as T2DM with HbA1c 8.4% and small lacunar infarction in bilateral white matter by MRI. Then, imeglimin 2000mg/day was started and HbA1c was decreased to 6.2% in April, 2020.
Discussion: Imeglimin has dual function for increasing insulin secretion and decreasing insulin resistance. It seems to be effective for elderly case, and will be used widely in the future.
掲載誌名
International Journal of Endocrinology and Diabetes
ISSN
26943875
出版者
Pubtexto Publishers
5
2
開始ページ
137
発行日
2022-05-28
権利情報
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系